| DC46922 |
CC-99677
Featured
|
CC-99677 is a potent, covalent, and irreversible inhibitor of the mitogen-activated protein (MAP) kinase-activated protein kinase-2 (MK2) pathway in both biochemical (IC50=156.3 nM) and cell based assays (EC50=89 nM). |
|
| DC47260 |
Zunsemetinib
Featured
|
Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases. |
|
| DC70037 |
RMM-46 |
RMM-46 is a selective and reversible covalent inhibitor for MSK/RSK-family kinases. |
|
| DC74335 |
MMI-0100 |
MMI-0100 is a cell-permeant peptide inhibitor of MAPKAP kinase 2 (MK2), inhibits MK2 and downstream fibrosis and inflammation. |
|
